Volitionrx (VNRX) Capital Expenditures Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | -84.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -84.89% |
| Jun 30, 2025 | 322.79% |
| Mar 31, 2025 | -96.38% |
| Dec 31, 2024 | 109.37% |
| Sep 30, 2024 | -82.36% |
| Dec 31, 2023 | -233.91% |
| Sep 30, 2023 | 138.11% |
| Dec 31, 2022 | 350.14% |
| Sep 30, 2022 | 129.53% |
| Jun 30, 2022 | 146.90% |
| Mar 31, 2022 | -74.24% |
| Dec 31, 2021 | -89.81% |
| Sep 30, 2021 | 72.06% |
| Jun 30, 2021 | -76.38% |
| Mar 31, 2021 | 246.34% |
| Dec 31, 2020 | 931.08% |
| Sep 30, 2020 | 167.18% |
| Jun 30, 2020 | 844.06% |
| Mar 31, 2020 | -194.99% |
| Dec 31, 2019 | -28.33% |
| Sep 30, 2019 | -111.40% |
| Jun 30, 2019 | 33.00% |
| Mar 31, 2019 | -284.81% |
| Dec 31, 2018 | -239.16% |
| Sep 30, 2018 | -155.09% |
| Jun 30, 2018 | -151.71% |
| Mar 31, 2018 | -93.07% |
| Dec 31, 2017 | -73.90% |
| Sep 30, 2017 | 400.39% |
| Dec 31, 2016 | 3,399.07% |
| Sep 30, 2016 | 273.18% |
| Dec 31, 2015 | 72.93% |
| Sep 30, 2015 | -97.75% |
| Jun 30, 2015 | 53.63% |
| Mar 31, 2015 | 1.30% |
| Dec 31, 2014 | 538,100.00% |
| Sep 30, 2014 | 25,093,700.00% |
| Mar 31, 2014 | 2,430.39% |
| Dec 31, 2013 | -99.99% |
| Sep 30, 2013 | -100.22% |
| Mar 31, 2013 | -98.11% |
| Dec 31, 2012 | -67.83% |
| Sep 30, 2012 | 102.25% |
| Jun 30, 2012 | 881.73% |